BioRestorative Therapies, Inc. (BRTX)
Nasdaq: BRTX · Services-Misc Health & Allied Services, NEC · Melville, NY · filing with the SEC since 2010
Filings
301 filings since 2017 beside 200 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Jun 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end; no report for this period is on file, and a late-filing notice (Form NT 10-Q) was filed Aug 14, 2026.
overdue since Aug 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 13, 2026.
Filings a yearinsider forms included
7922597454484040
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Nov 12, 2026.Auditor change (8-K item 4.01): 3 times in the last 36 months, the newest Sep 10, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Aug 25, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest May 24, 2024.SEC letters: 4 in the last 36 months, the newest Feb 10, 2026.A late-filing notice, Form NT 10-Q, filed Aug 14, 2026.A late-filing notice, Form NT 10-Q, filed May 16, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 10, 2026
8-K/A items 4.01, 8.01, 9.01
Auditor change; Other event · Current report, amended
Aug 26, 2026
Sep 2, 2026
8-K items 3.03, 5.03, 7.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Sep 2, 2026
8-K items 4.01, 5.02, 9.01
Auditor change; Officer or director change · Current report
Aug 26, 2026
Jun 12, 2026
8-K items 1.01, 5.02, 9.01
Major agreement signed; Officer or director change · Current report
Jun 10, 2026
May 29, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
May 26, 2026
Feb 17, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Feb 11, 2026
40 of 301 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.